Fibrocell Science Inc. (FCSC) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
405 EAGLEVIEW BOULEVARD EXTON, PA 19341 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 13,675 | 11,322 | 14,430 | 16,111 | 15,410 | 12,201 | |||
| Cash and cash equivalents | 13,675 | 11,322 | 14,430 | 16,111 | 15,410 | 12,201 | |||
| Receivables | 1,911 | 294 | |||||||
| Contract with customer, asset, after allowance for credit loss | 8,439 | ||||||||
| Other undisclosed current assets | 841 | 923 | 105 | 294 | 455 | 497 | |||
| Total current assets: | 24,866 | 12,539 | 14,535 | 16,405 | 15,865 | 12,698 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 4,421 | ✕ | ✕ | ✕ | ✕ | ||||
| Property, plant and equipment | 1,289 | 1,183 | 1,222 | 1,295 | 1,374 | 1,408 | |||
| Contract with customer, asset, after allowance for credit loss | 4,279 | ||||||||
| Other noncurrent assets | 1 | 1 | 1 | 1 | 39 | 39 | |||
| Other undisclosed noncurrent assets | 4,412 | ||||||||
| Total noncurrent assets: | 9,990 | 5,596 | 1,223 | 1,296 | 1,413 | 1,447 | |||
| TOTAL ASSETS: | 34,856 | 18,135 | 15,758 | 17,701 | 17,278 | 14,145 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 3,100 | 3,261 | 1,922 | 1,748 | 1,772 | 1,513 | |||
| Taxes payable | 634 | ||||||||
| Accounts payable | 1,085 | 1,534 | 452 | 782 | 635 | 508 | |||
| Accrued liabilities | 1,381 | 1,727 | 1,470 | 966 | 1,137 | 1,005 | |||
| Debt | 186 | ||||||||
| Deferred rent credit | 150 | ||||||||
| Due to related parties | 3,815 | 53 | 100 | 63 | 276 | 374 | |||
| Other undisclosed current liabilities | 175 | ||||||||
| Total current liabilities: | 7,101 | 3,489 | 2,172 | 1,811 | 2,048 | 1,887 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 5,057 | ||||||||
| Liabilities, other than long-term debt | 2,557 | 1,419 | 2,139 | 3,682 | 3,766 | 4,004 | |||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 805 | ||
| Deferred rent credit | 665 | 812 | 809 | ||||||
| Operating lease, liability | 5,057 | ✕ | ✕ | ✕ | ✕ | ||||
| Derivative instruments and hedges, liabilities | 2,557 | 1,419 | 1,474 | 2,870 | 2,957 | 3,199 | |||
| Other undisclosed noncurrent liabilities | 2,278 | 7,224 | 1,890 | 2,024 | 2,096 | 1,995 | |||
| Total noncurrent liabilities: | 9,892 | 8,643 | 4,029 | 5,706 | 5,862 | 5,999 | |||
| Total liabilities: | 16,993 | 12,132 | 6,201 | 7,517 | 7,910 | 7,886 | |||
| Equity | |||||||||
| Equity, attributable to parent | 17,863 | 6,003 | 9,557 | 10,184 | 9,368 | 6,259 | |||
| Common stock | 10 | 10 | 10 | 9 | 8 | 28 | |||
| Additional paid in capital | 198,856 | 198,739 | 198,627 | 197,632 | 193,958 | 187,935 | |||
| Accumulated deficit | (181,003) | (192,746) | (189,080) | (187,457) | (184,598) | (181,704) | |||
| Total equity: | 17,863 | 6,003 | 9,557 | 10,184 | 9,368 | 6,259 | |||
| TOTAL LIABILITIES AND EQUITY: | 34,856 | 18,135 | 15,758 | 17,701 | 17,278 | 14,145 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 21,792 | |||||||
| Cost of revenue (Cost of Goods and Services Sold) | (5,172) | |||||||
| Gross profit: | 16,620 | |||||||
| Operating expenses | (3,056) | (3,813) | (3,092) | (3,042) | (2,971) | (3,284) | ||
| Other undisclosed operating income (loss) | 4 | (44) | (134) | (63) | (106) | 303 | ||
| Operating income (loss): | 13,568 | (3,857) | (3,226) | (3,105) | (3,077) | (2,981) | ||
| Interest and debt expense | (200) | (197) | (196) | (194) | (191) | (190) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | 13,368 | (4,054) | (3,422) | (3,299) | (3,268) | (3,171) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (991) | 388 | 1,799 | 440 | 374 | 270 | ||
| Income (loss) from continuing operations before income taxes: | 12,377 | (3,666) | (1,623) | (2,859) | (2,894) | (2,901) | ||
| Income tax expense (benefit) | (634) | |||||||
| Income (loss) from continuing operations: | 11,743 | (3,666) | (1,623) | (2,859) | (2,894) | (2,901) | ||
| Income (loss) before gain (loss) on sale of properties: | 11,743 | (3,666) | (1,623) | (2,859) | (2,894) | (2,901) | ||
| Net income (loss) attributable to parent: | 11,743 | (3,666) | (1,623) | (2,859) | (2,894) | (2,901) | ||
| Preferred stock dividends and other adjustments | (86) | (85) | (86) | (85) | (83) | (82) | ||
| Other undisclosed net loss available to common stockholders, basic | (145) | (140) | (136) | (130) | (126) | (121) | ||
| Net income (loss) available to common stockholders, basic: | 11,512 | (3,891) | (1,845) | (3,074) | (3,103) | (3,104) | ||
| Convertible preferred dividends | 145 | |||||||
| Other undisclosed net income available to common stockholders, diluted | 1,424 | |||||||
| Net income (loss) available to common stockholders, diluted: | 13,081 | (3,891) | (1,845) | (3,074) | (3,103) | (3,104) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 11,743 | (3,666) | (1,623) | (2,859) | (2,894) | (2,901) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 11,743 | (3,666) | (1,623) | (2,859) | (2,894) | (2,901) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.